• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsFinancialsHolding CompaniesTcgx Acquisition
    Picture of Tcgx Acquisition logo

    TCGX — Tcgx Acquisition News Story

    $12.360.000.00%
    us flag iconLast trade - 00:00
    FinancialsSpeculativeMicro Cap
    • Market Cap
    • Enterprise Value
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • TCGX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    TCGX Dividends
    All News

    NASDAQ RESUMED AT 11:00 AM

    Picture of Tcgx Acquisition logoTcgx Acquisition
    05/08/2026 16:00
    NASDAQ RESUMED  AT 11:00 AM

    Recent news on Tcgx Acquisition

    See all news
    • Brief: Trigemx Bio And Tcgx Acquisition Corp. Announce Business Combination Agreement To Create Publicly Listed Company To Develop Elismetrep, A Potential First-In-Class Treatment For Migraine

      Mon 12:34
    • Brief: TCGX Acquisition Corp. Ii Announces Pricing Of $100,000,000 Initial Public Offering

      15/10/2026 22:18
    • Brief: Tcgx Acquisition Corp II Files $100 Million IPO For 10 Million Class A Shares

      25/09/2026 22:40
    • NASDAQ RESUMED AT 11:00 AM

      05/08/2026 16:00
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

      05/08/2026 09:00

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.